Sort
15,440 grants matching “organoids”
Gastrointestinal microbiota interactions modulating gastric cancer progression
$244,253Nina Reda Salama · Fred Hutchinson Cancer Center · R21 · FY2022 · CA
Understanding the role of the stromal cell niche in intestinal stem cell aging
$244,021Norihiro Goto · Weill Medical Coll Of Cornell Univ · R00 · FY2025 · AG
Human cerebral organoids as a model system for neural development and disease
$244,020Momoko Watanabe · University Of California-Irvine · R00 · FY2022 · HD
Human cerebral organoids as a model system for neural development and disease
$244,020Momoko Watanabe · University Of California-Irvine · R00 · FY2021 · HD
Patterns and Mechanisms Underlying Somatic Mutations Across Long-Lived Bats
$244,019Juan Manuel Vazquez · Pennsylvania State University, The · R00 · FY2025 · AG
Platform to develop targeted therapies for aggressive less common gynecological cancers
$243,836Fiona Simpkins · University Of Pennsylvania · U54 · FY2024 · CA
The role of senescence in severe COVID-19
$243,750Tobias D. Raabe · University Of Pennsylvania · R21 · FY2024 · AI
Montreal-Boston Collaborative GRC
$243,628John D. Rioux · Montreal Heart Institute · U01 · FY2024 · DK
(PQ1) Mechanisms for Early Onset Colorectal Cancer
$243,568Daniel W Rosenberg · University Of Connecticut Sch Of Med/Dnt · R21 · FY2021 · CA
Stanford Cancer Institute
$243,465Steven E Artandi · Stanford University · P30 · FY2019 · CA
Targeting Glutamine Uptake via ASCT2 Inhibition in MYCN-amplified Neuroblastomas
$243,398Eric James Rellinger · University Of Kentucky · P20 · FY2025 · GM
Training in the Molecular Basis of Autoimmunity and Autoinflammation
$243,395Katherine A Fitzgerald · Univ Of Massachusetts Med Sch Worcester · T32 · FY2023 · AI
Liver-enriched Transcription Factors as Prognostic Markers and Therapeutic Targets in Alcoholic Hepatitis
$243,345Ramon Bataller · University Of Pittsburgh At Pittsburgh · U01 · FY2021 · AA
Patient-derived organoids reveal rectal cancers develop radiosensitivity
$243,278Richard N Kolesnick · Sloan-Kettering Inst Can Research · R21 · FY2022 · CA
Chromatin Modifier Gene Mutation and Enhancer Dysfunction in Bladder Cancer
$243,205Byron H Lee · Cleveland Clinic Lerner Com-Cwru · K08 · FY2020 · CA
Chromatin Modifier Gene Mutation and Enhancer Dysfunction in Bladder Cancer
$243,205Byron H Lee · Cleveland Clinic Lerner Com-Cwru · K08 · FY2021 · CA
Chromatin Modifier Gene Mutation and Enhancer Dysfunction in Bladder Cancer
$243,205Byron H Lee · University Of Tx Md Anderson Can Ctr · K08 · FY2023 · CA
Chromatin Modifier Gene Mutation and Enhancer Dysfunction in Bladder Cancer
$243,205Byron H Lee · Cleveland Clinic Lerner Com-Cwru · K08 · FY2019 · CA
Chromatin Modifier Gene Mutation and Enhancer Dysfunction in Bladder Cancer
$243,205Byron H Lee · Cleveland Clinic Lerner Com-Cwru · K08 · FY2022 · CA
Experimental Therapeutics Program
$243,163John D Minna · Ut Southwestern Medical Center · P30 · FY2025 · CA
Neurodevelopmental Stem Cell core
$243,131Evangelos Kiskinis · Northwestern University At Chicago · P50 · FY2025 · MH
Neurodevelopmental Stem Cell core
$243,130Evangelos Kiskinis · Northwestern University At Chicago · P50 · FY2024 · MH
Role of the Rett Syndrome-causing gene MeCP2 in 3D chromosomal organization and rescue of cellular disease phenotypes
$243,123X. Shawn Liu · Columbia University Health Sciences · R00 · FY2020 · MH
Pathology Core
$243,062David Kolin · Dana-Farber Cancer Inst · P50 · FY2024 · CA
South Texas Alzheimer's Disease Center Genetics and Multiomics Core
$243,004Sudha Seshadri · University Of Texas Hlth Science Center · P30 · FY2023 · AG